Future studies should thus aim at elucidating the therapeutic efficacy of normalization of PGC-1α levels with viral vectors or pharmacological tools on retinal degeneration in retinitis pigmentosa and other retinal pathologies. The gene discussed is PPARGC1A; the disease is retinitis pigmentosa.